Parastomal HerniaIDOPSNCT07866339
Improving Decisions and Outcomes in Parastomal Hernia Surgery
An observational study of Parastomal Hernia, run by Erling Oma at 1 site in Denmark.
Trial summary
The goal of this observational study is to help improve decisions about planned surgery for parastomal hernia and understand the results of treatment. A parastomal hernia is a bulge that develops around a stoma, an opening in the abdomen created during surgery to allow bowel contents to pass into a bag. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Parastomal Hernia
- How many people
- 250 participants
- Where
- 1 siteDenmark
- Study dates
- Oct 2026to Sep 2036
- How long will I take part?
- 5 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients assessed in the specialist stoma outpatient clinic at Abdominalcenter K, Bispebjerg Hospital.
Who may be able to join
- Parastomal hernia confirmed by clinical assessment and imaging.
- Assessed in the specialist stoma outpatient clinic at Abdominalcenter K, Bispebjerg Hospital.
- Able to understand the oral and written participant information.
- Provides written informed consent.
Who cannot join
- Diagnosis of parastomal hernia ruled out.
- Unwilling or unable to provide informed consent.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Denmark1 site
Bispebjerg Hospital
Copenhagen
Erling Oma, MD, PhD, 004520367252, erling.oma@regionh.dk
About this study
The goal of this observational study is to help improve decisions about planned surgery for parastomal hernia and understand the results of treatment. A parastomal hernia is a bulge that develops around a stoma, an opening in the abdomen created during surgery to allow bowel contents to pass into a bag. These hernias can cause discomfort, problems with stoma care, and reduced quality of life. Surgery may help, but it also carries risks, and the hernia may return.
The study will include approximately 250 patients assessed for parastomal hernia at Bispebjerg Hospital in Denmark. It will include both patients who undergo planned hernia surgery and patients who are managed without surgery.
Read more
The main questions are:
What are the short- and long-term results of planned parastomal hernia surgery, including complications, hospital readmissions, further operations, return of the hernia, and quality of life?
How often do patients who are initially not offered planned surgery need emergency hospital care or emergency surgery?
Which patient characteristics, symptoms, and hernia features are associated with treatment decisions and outcomes?
How does quality of life change over time in patients managed with and without surgery?
Participants will receive their usual care. Decisions about treatment will be made by patients and their clinical team independently of study participation. The study does not assign treatments or require additional invasive examinations.
Researchers will collect information from routine clinical assessments, imaging, medical records, and questionnaires. Participants will complete two questionnaires about stoma-related quality of life and general health, called Stoma-QOL and EQ-5D-5L, when they join the study and at subsequent outpatient assessments.
Participants will also be invited to complete the questionnaires at home through secure digital mail. Patients who have not undergone hernia surgery will receive annual invitations starting one year after joining the study. Patients who undergo planned hernia surgery will receive invitations after surgery and annually thereafter. This allows researchers to follow quality of life over time in both groups.
Participants will be followed for up to five years from joining the study. The findings may help clinicians and patients make better-informed decisions about whether to proceed with planned parastomal hernia surgery.
Read the detailed description
IDOPS is a prospective observational cohort and clinical registry designed to establish a longitudinal evidence base for patient selection and treatment of parastomal hernia. The registry captures the clinical pathway from initial specialist assessment through treatment decisions, reassessments, elective surgery where applicable, and emergency presentations. Treatment is determined through routine clinical care.
Registry structure and procedures
Data are collected in a dedicated REDCap database. The initial assessment is recorded once, while repeatable instruments capture subsequent treatment decisions, outpatient reassessments, operations, postoperative complications, acute admissions, and acute interventions. This structure allows multiple events to be recorded for each participant while preserving their chronological relationship.
Treatment decisions include referral for multidisciplinary hernia discussion and the reasons for non-operative management. These distinguish between an unfavourable balance of symptom burden and surgical risk, lack of suitability for surgery, and a patient's decision to decline an offered operation. Changes in management are recorded prospectively.
Patient-reported data are collected during outpatient assessments and through automated questionnaire invitations delivered via secure digital mail. Annual invitations for patients who have not undergone surgery are scheduled relative to enrolment. Postoperative invitations are scheduled relative to the first operation recorded in the registry. Invitation logic incorporates questionnaire completion status and whether follow-up remains active.
Data dictionary and validation
The REDCap data dictionary defines variable names, field labels, response options, coding, branching logic, required fields, and applicable validation rules. Calculated fields are used for derived variables, including body mass index and questionnaire scores. Hernia characteristics are recorded using the European Hernia Society classification, with primary and recurrent hernias distinguished.
Data-entry controls include predefined response categories, date validation, required fields, and numerical range checks where appropriate. For example, height and weight fields have predefined permitted ranges. Conditional fields are displayed according to preceding responses to support consistent recording of treatment decisions and clinical events.
Data quality assurance and source verification
The study team will review registry data for completeness, duplicate records, implausible values, inconsistent responses, and discrepancies in the chronological sequence of clinical events. Identified discrepancies will be checked against the relevant source and corrected where possible.
Medical records, imaging reports, and operative reports will be used to verify clinical data when entries are incomplete, inconsistent, or uncertain. Patient-reported questionnaire responses will be retained as reported by the participant. Corrections to clinical data and changes to the database structure will be documented using REDCap's logging functionality.
Registry operations and change management
The study team will maintain documented procedures for recruitment and consent recording, data entry, follow-up administration, discrepancy resolution, data extraction, analysis, and reporting. Postoperative complications and acute events will be captured from routine clinical documentation. Database changes will be reviewed for their effects on existing records, branching logic, calculated fields, and automated invitations before implementation. Analyses will use dated data extracts and documented variable definitions.
Sample size considerations
The anticipated cohort size is approximately 250 participants recruited over five years, based on expected clinical volume. The study is exploratory and is not powered to test a single treatment effect. The number of participants with available follow-up and the number of observed events will determine the precision of estimates and the complexity of adjusted analyses. Development of prediction models will depend on whether sufficient data and events are available; subsequent validation would require an appropriate validation dataset.
Missing data
Missing data will be assessed by variable and follow-up time point. Where possible, missing clinical information will be retrieved from source records. Unavailable information will remain missing rather than being interpreted as the absence of an event. Unresolved inconsistent or implausible values will be treated as missing for the relevant analysis.
Questionnaire response rates will be reported at each scheduled assessment. Scoring will follow the applicable questionnaire instructions. Analyses will distinguish non-response from assessments that are no longer applicable because of death, withdrawal, or stoma reversal. The choice between complete-case analysis and methods such as multiple imputation will depend on the extent and likely mechanism of missingness. Material assumptions will be examined through sensitivity analyses where feasible.
Statistical analysis
Analyses will describe patient characteristics, treatment pathways, operative practice, and longitudinal clinical and patient-reported data. Estimates will be presented with measures of uncertainty. Time-to-event analyses will use a clearly defined time origin appropriate to the question, such as enrolment or surgery. Death will be considered as a competing event where relevant.
Changes in patient-reported scores will be analysed using methods that account for repeated measurements within participants. Multivariable analyses will explore associations between patient characteristics, treatment decisions, operative techniques, and subsequent outcomes, with model complexity limited by the available sample and event counts.
Patients may transition from non-operative management to surgery during follow-up. Analyses involving treatment status will account for the timing of this transition where relevant. Comparisons between management strategies or operative techniques will be interpreted in light of confounding by indication and will not, by themselves, establish causal treatment effects.
- Conditions
- Parastomal Hernia
- Keywords
- parastomal hernia, quality of life, patient selection, parastomal hernia repair
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| non-operative management | patients who are not offered or do not want elective parastomal hernia repair | |
| operative management | patients who undergo parastomal hernia repair |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of hernia recurrence
hernia recurrence following elective parastomal hernia repair
Measured: 5 years
Secondary outcomes (3)
Rate of emergency presentations
acute hernia-related complications requiring emergency care +/- emergency surgery
Measured: 5 years
Changes in stoma related quality of life
Stoma related quality of life changes over time for both patients treated conservatively and with surgery. Assessed with the stoma-related quality of life questionnare Stoma Quality of Life questionnaire (Stoma-QOL) at first visit, 3 months postoperatively for patients who undergo elective parastomal hernia repair, and subsequently once a year until 5 years for all included patients.
Stoma-QOL: A 20-item, stoma-specific patient-reported outcome measure assessing quality of life in patients with a colostomy or ileostomy. The total score ranges from 0 to 100, with higher scores indicating better stoma-related quality of life.
Measured: 5 years
changes in general quality of life
Quality of life changes over time for both patients treated conservatively and with surgery. Assessed with the quality of life questionnare EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L) at first visit, 3 months postoperatively for patients who undergo elective parastomal hernia repair, and subsequently once a year until 5 years for all included patients.
EQ-5D-5L: A generic patient-reported measure of health-related quality of life assessing five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each rated on five levels of severity. Using the Danish EQ-5D-5L value set, responses are converted into an index value ranging from -0.757 to 1.000, where higher values indicate better health-related quality of life and 1.000 represents full health. The instrument also includes the EQ Visual Analogue Scale (EQ VAS), ranging from 0 (worst health imaginable) to 100 (best health imaginable).
Measured: 5 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2026
- Study startOct 2026 (estimated)
- Primary completionSep 2031 (estimated)
- Study completionSep 2036 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parastomal HerniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 250 participants (estimated)
- Target duration
- 5 Years
Sponsor and investigators
- Lead sponsor
- Erling Oma
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Erling Oma, Bispebjerg Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07866339
- Sponsor's protocol ID
- p-2026-22106
- Acronym
- IDOPS
- Status last verified
- Oct 2026
- First submitted
- 30 Sep 2026
- Last updated
- 8 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: GDPR regulations
Study at a glance
From the registry record, last updated by the sponsor on 8 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improving Decisions and Outcomes in Parastomal Hernia Surgery
- ClinicalTrials.gov ID
- NCT07866339
- Acronym / sponsor ID
- IDOPS / p-2026-22106
- Conditions
- Parastomal Hernia
- Keywords
- parastomal hernia, quality of life, patient selection, parastomal hernia repair
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 250 participants (estimated)
- Lead sponsor
- Erling OmaUniversity, hospital or other
- Study start
- Oct 2026 (estimated)
- Primary completion
- Sep 2031 (estimated)
- Study completion
- Sep 2036 (estimated)
- First posted
- 8 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to help improve decisions about planned surgery for parastomal hernia and understand the results of treatment. A parastomal hernia is a bulge that develops around a stoma, an opening in the abdomen created during surgery to allow bowel contents to pass into a bag. These hernias can cause discomfort, problems with stoma care, and reduced quality of life. Surgery may help, but it also carries risks, and the hernia may return.
The study will include approximately 250 patients assessed for parastomal hernia at Bispebjerg Hospital in Denmark. It will include both patients who undergo planned hernia surgery and patients who are managed without surgery.
The main questions are:
What are the short- and long-term results of planned parastomal hernia surgery, including complications, hospital readmissions, further operations, return of the hernia, and quality of life?
How often do patients who are initially not offered planned surgery need emergency hospital care or emergency surgery?
Which patient characteristics, symptoms, and hernia features are associated with treatment decisions and outcomes?
How does quality of life change over time in patients managed with and without surgery?
Participants will receive their usual care. Decisions about treatment will be made by patients and their clinical team independently of study participation. The study does not assign treatments or require additional invasive examinations.
Researchers will collect information from routine clinical assessments, imaging, medical records, and questionnaires. Participants will complete two questionnaires about stoma-related quality of life and general health, called Stoma-QOL and EQ-5D-5L, when they join the study and at subsequent outpatient assessments.
Participants will also be invited to complete the questionnaires at home through secure digital mail. Patients who have not undergone hernia surgery will receive annual invitations starting one year after joining the study. Patients who undergo planned hernia surgery will receive invitations after surgery and annually thereafter. This allows researchers to follow quality of life over time in both groups.
Participants will be followed for up to five years from joining the study. The findings may help clinicians and patients make better-informed decisions about whether to proceed with planned parastomal hernia surgery.
Detailed description
IDOPS is a prospective observational cohort and clinical registry designed to establish a longitudinal evidence base for patient selection and treatment of parastomal hernia. The registry captures the clinical pathway from initial specialist assessment through treatment decisions, reassessments, elective surgery where applicable, and emergency presentations. Treatment is determined through routine clinical care.
Registry structure and procedures
Data are collected in a dedicated REDCap database. The initial assessment is recorded once, while repeatable instruments capture subsequent treatment decisions, outpatient reassessments, operations, postoperative complications, acute admissions, and acute interventions. This structure allows multiple events to be recorded for each participant while preserving their chronological relationship.
Treatment decisions include referral for multidisciplinary hernia discussion and the reasons for non-operative management. These distinguish between an unfavourable balance of symptom burden and surgical risk, lack of suitability for surgery, and a patient's decision to decline an offered operation. Changes in management are recorded prospectively.
Patient-reported data are collected during outpatient assessments and through automated questionnaire invitations delivered via secure digital mail. Annual invitations for patients who have not undergone surgery are scheduled relative to enrolment. Postoperative invitations are scheduled relative to the first operation recorded in the registry. Invitation logic incorporates questionnaire completion status and whether follow-up remains active.
Data dictionary and validation
The REDCap data dictionary defines variable names, field labels, response options, coding, branching logic, required fields, and applicable validation rules. Calculated fields are used for derived variables, including body mass index and questionnaire scores. Hernia characteristics are recorded using the European Hernia Society classification, with primary and recurrent hernias distinguished.
Data-entry controls include predefined response categories, date validation, required fields, and numerical range checks where appropriate. For example, height and weight fields have predefined permitted ranges. Conditional fields are displayed according to preceding responses to support consistent recording of treatment decisions and clinical events.
Data quality assurance and source verification
The study team will review registry data for completeness, duplicate records, implausible values, inconsistent responses, and discrepancies in the chronological sequence of clinical events. Identified discrepancies will be checked against the relevant source and corrected where possible.
Medical records, imaging reports, and operative reports will be used to verify clinical data when entries are incomplete, inconsistent, or uncertain. Patient-reported questionnaire responses will be retained as reported by the participant. Corrections to clinical data and changes to the database structure will be documented using REDCap's logging functionality.
Registry operations and change management
The study team will maintain documented procedures for recruitment and consent recording, data entry, follow-up administration, discrepancy resolution, data extraction, analysis, and reporting. Postoperative complications and acute events will be captured from routine clinical documentation. Database changes will be reviewed for their effects on existing records, branching logic, calculated fields, and automated invitations before implementation. Analyses will use dated data extracts and documented variable definitions.
Sample size considerations
The anticipated cohort size is approximately 250 participants recruited over five years, based on expected clinical volume. The study is exploratory and is not powered to test a single treatment effect. The number of participants with available follow-up and the number of observed events will determine the precision of estimates and the complexity of adjusted analyses. Development of prediction models will depend on whether sufficient data and events are available; subsequent validation would require an appropriate validation dataset.
Missing data
Missing data will be assessed by variable and follow-up time point. Where possible, missing clinical information will be retrieved from source records. Unavailable information will remain missing rather than being interpreted as the absence of an event. Unresolved inconsistent or implausible values will be treated as missing for the relevant analysis.
Questionnaire response rates will be reported at each scheduled assessment. Scoring will follow the applicable questionnaire instructions. Analyses will distinguish non-response from assessments that are no longer applicable because of death, withdrawal, or stoma reversal. The choice between complete-case analysis and methods such as multiple imputation will depend on the extent and likely mechanism of missingness. Material assumptions will be examined through sensitivity analyses where feasible.
Statistical analysis
Analyses will describe patient characteristics, treatment pathways, operative practice, and longitudinal clinical and patient-reported data. Estimates will be presented with measures of uncertainty. Time-to-event analyses will use a clearly defined time origin appropriate to the question, such as enrolment or surgery. Death will be considered as a competing event where relevant.
Changes in patient-reported scores will be analysed using methods that account for repeated measurements within participants. Multivariable analyses will explore associations between patient characteristics, treatment decisions, operative techniques, and subsequent outcomes, with model complexity limited by the available sample and event counts.
Patients may transition from non-operative management to surgery during follow-up. Analyses involving treatment status will account for the timing of this transition where relevant. Comparisons between management strategies or operative techniques will be interpreted in light of confounding by indication and will not, by themselves, establish causal treatment effects.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 5 Years
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| non-operative management | – | –patients who are not offered or do not want elective parastomal hernia repair |
| operative management | – | –patients who undergo parastomal hernia repair |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients assessed in the specialist stoma outpatient clinic at Abdominalcenter K, Bispebjerg Hospital.
Key inclusion criteria (4 listed)
- Parastomal hernia confirmed by clinical assessment and imaging.
- Assessed in the specialist stoma outpatient clinic at Abdominalcenter K, Bispebjerg Hospital.
- Able to understand the oral and written participant information.
- Provides written informed consent.
Key exclusion criteria (2 listed)
- Diagnosis of parastomal hernia ruled out.
- Unwilling or unable to provide informed consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Rate of hernia recurrence
Time frame: 5 years
hernia recurrence following elective parastomal hernia repair
3 secondary outcomes
Rate of emergency presentations
Time frame: 5 years
Changes in stoma related quality of life
Time frame: 5 years
changes in general quality of life
Time frame: 5 years
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Oct 2026.
- Individual participant dataSharing planned: No. GDPR regulations
Related trials for Parastomal Hernia
RecruitingObservational study
Risk Factors for Mesh Infection After Abdominal Wall Reconstruction
Incisional Hernia, Ventral Hernia
Recruiting
Comparing the Incidence of Parastomal Hernia After Mesenteric Molding Suturing and Non-molding Suturing in Colostomy Surgery
Parastomal Hernia
Recruiting
Laparoscopic Total Extraperitoneal Plasty as a Modification of Sugabecker's Operation
Parastomal Hernia
Not yet recruiting
A Prospective Randomized Controlled Trial Comparing Extraperitoneal Stoma Creation Via the Arcuate Line Approach Versus Conventional Transperitoneal Stoma Formation for the Prevention of Parastomal Hernia
Parastomal Hernia, Rectal Surgery
RecruitingObservational study
Prevention of Postoperative Hernias in Emergency Surgery
Incarcerated Hernia, Appendicitis Acute
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Parastomal Hernia, run by Erling Oma at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Erling Oma, MD, PhD (004520367152, erling.oma@regionh.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of hernia recurrence (time frame: 5 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.